Centene Corporation $CNC is Pine Valley Investments Ltd Liability Co’s 10th Largest Position

Pine Valley Investments Ltd Liability Co increased its holdings in Centene Corporation (NYSE:CNC) by 1.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,010,459 shares of the company’s stock after acquiring an additional 9,540 shares during the quarter. Centene makes up about 1.5% of Pine Valley Investments Ltd Liability Co’s holdings, making the stock its 10th biggest position. Pine Valley Investments Ltd Liability Co owned 0.20% of Centene worth $33,082,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Daytona Street Capital LLC purchased a new stake in shares of Centene during the fourth quarter worth approximately $2,566,000. Chicago Partners Investment Group LLC raised its position in Centene by 114.1% during the 4th quarter. Chicago Partners Investment Group LLC now owns 45,798 shares of the company’s stock worth $1,885,000 after buying an additional 24,411 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in shares of Centene by 426.8% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 2,318,075 shares of the company’s stock worth $95,389,000 after acquiring an additional 1,878,064 shares during the period. Ninety One UK Ltd boosted its holdings in shares of Centene by 162.6% in the fourth quarter. Ninety One UK Ltd now owns 1,720,422 shares of the company’s stock valued at $70,795,000 after acquiring an additional 1,065,223 shares in the last quarter. Finally, Gateway Investment Advisers LLC increased its stake in shares of Centene by 599.0% during the fourth quarter. Gateway Investment Advisers LLC now owns 52,816 shares of the company’s stock worth $2,173,000 after acquiring an additional 45,260 shares during the period. 93.63% of the stock is owned by hedge funds and other institutional investors.

Key Centene News

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Strong Q2 results and raised outlook: Centene reported adjusted earnings of $2.51 per share, well above the $1.09 consensus estimate, while revenue rose 9.9% year over year to $53.58 billion. The insurer also raised its 2026 earnings outlook to at least $4.80 per share, citing contained medical costs. Centene Lifts 2026 Outlook as Insurer Contains Medical Costs
• Positive Sentiment: Analyst support has strengthened: Zacks Research upgraded CNC from “hold” to “strong buy,” while Truist maintained its buy rating. Robert W. Baird also expects the stock to rise, providing additional support for the recent rally. Zacks.com Truist Financial Keeps Their Buy Rating on Centene
• Positive Sentiment: Momentum and valuation remain favorable: Zacks included Centene among its Rank #1 momentum stocks, and other analyses describe CNC as potentially undervalued following its earnings recovery. These reports may attract momentum and value-oriented investors. Best Momentum Stock to Buy
• Neutral Sentiment: Relative investment appeal: A comparison with UnitedHealth favors UNH because of its diversified platform, Optum growth and artificial-intelligence investments. The assessment does not identify a new negative development at Centene but could limit CNC’s appeal among managed-care investors. UnitedHealth vs. Centene
• Negative Sentiment: Medicaid and membership concerns persist: Coverage highlights declining membership and ongoing Medicaid-related pressure, which could challenge revenue growth and margins even as medical-cost trends improve. Medicaid Weighs on Centene

Centene Stock Performance

NYSE CNC opened at $62.23 on Monday. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.71. The stock has a market cap of $30.74 billion, a price-to-earnings ratio of -5.96, a price-to-earnings-growth ratio of 0.33 and a beta of 1.08. Centene Corporation has a fifty-two week low of $25.08 and a fifty-two week high of $69.36. The business has a fifty day moving average of $63.87 and a 200-day moving average of $50.30.

Centene (NYSE:CNC) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $2.51 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $1.42. The firm had revenue of $53.58 billion during the quarter, compared to analysts’ expectations of $47.64 billion. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the business posted ($0.16) EPS. Centene has set its FY 2026 guidance at 4.800- EPS. As a group, analysts predict that Centene Corporation will post 4.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CNC. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $40.00 price objective on shares of Centene in a report on Wednesday, April 29th. Mizuho set a $63.00 price target on Centene and gave the company a “neutral” rating in a report on Monday, June 8th. Raymond James Financial set a $75.00 price objective on Centene in a report on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft upgraded Centene from a “hold” rating to a “buy” rating and increased their price objective for the stock from $53.00 to $80.00 in a research report on Wednesday, May 20th. Finally, Morgan Stanley set a $66.00 price target on shares of Centene in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Centene has an average rating of “Hold” and a consensus target price of $67.00.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.